Search
Search titles only
By:
Search titles only
By:
Menu
Forums
New posts
Search forums
Home
What's new
New posts
Latest activity
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Reply to thread
Home
Heath
Alternative Medicine
Pogostemon cablin extract as an anticancer agent on human acute myeloid leukemia.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="greenmedinfo" data-source="post: 2021"><p>PMID: Food Sci Nutr. 2021 Jun ;9(6):3209-3218. Epub 2021 May 2. PMID: 34136185 Abstract Title: extract as an anticancer agent on human acute myeloid leukemia. Abstract: has been indicated to treat many kinds of diseases and the progression of cancers, such as colorectal cancer. However, the effects ofextract (PPa extract) against acute myeloid leukemia have not been investigated. Thus, this study explored the anticancer potential of PPa extract and its mechanism in HL-60 cells. The MTT assay results showed that PPa extract significantly inhibited the proliferation of HL-60 cells in a dose-dependent manner and affected cell morphology, causing cell shrinkage and the formation of debris. PPa extract blocked cell cycle progression at the G/Gphase in a dose- and time-dependent manner and induced cell apoptosis, as shown by the observation of DNA fragments and apoptotic bodies. Furthermore, PPa extract caused the accumulation of a population of cells at G/Gphase via a reduction in p-Rb, increasing p21 expression, and downregulating cell cycle regulator protein expression. Then, PPa extract was found to activate the extrinsic and intrinsic apoptosis pathways, leading to cell death. These data demonstrated that PPa extract exerted inhibitory activity and triggered cell apoptosis in HL-60 cells and that PPa extract might be a chemopreventive agent for cancer therapy. </p><p><a href="https://www.greenmedinfo.com/article/pogostemon-cablin-extract-anticancer-agent-human-acute-myeloid-leukemia" target="_blank">read more</a></p></blockquote><p></p>
[QUOTE="greenmedinfo, post: 2021"] PMID: Food Sci Nutr. 2021 Jun ;9(6):3209-3218. Epub 2021 May 2. PMID: 34136185 Abstract Title: extract as an anticancer agent on human acute myeloid leukemia. Abstract: has been indicated to treat many kinds of diseases and the progression of cancers, such as colorectal cancer. However, the effects ofextract (PPa extract) against acute myeloid leukemia have not been investigated. Thus, this study explored the anticancer potential of PPa extract and its mechanism in HL-60 cells. The MTT assay results showed that PPa extract significantly inhibited the proliferation of HL-60 cells in a dose-dependent manner and affected cell morphology, causing cell shrinkage and the formation of debris. PPa extract blocked cell cycle progression at the G/Gphase in a dose- and time-dependent manner and induced cell apoptosis, as shown by the observation of DNA fragments and apoptotic bodies. Furthermore, PPa extract caused the accumulation of a population of cells at G/Gphase via a reduction in p-Rb, increasing p21 expression, and downregulating cell cycle regulator protein expression. Then, PPa extract was found to activate the extrinsic and intrinsic apoptosis pathways, leading to cell death. These data demonstrated that PPa extract exerted inhibitory activity and triggered cell apoptosis in HL-60 cells and that PPa extract might be a chemopreventive agent for cancer therapy. [URL='https://www.greenmedinfo.com/article/pogostemon-cablin-extract-anticancer-agent-human-acute-myeloid-leukemia']read more[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Home
Heath
Alternative Medicine
Pogostemon cablin extract as an anticancer agent on human acute myeloid leukemia.
Top
Bottom
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…